Undated
Spin-out of New Leaf from Sprout.
| Name | Type | Mentions | |
|---|---|---|---|
| New Leaf | organization | 90 | View Entity |
| Sprout | organization | 56 | View Entity |
HOUSE_OVERSIGHT_024026.jpg
This document is page 15 of a confidential corporate report or prospectus for an entity named "New Leaf" (likely New Leaf Venture Partners). It profiles Craig L. Slutzkin, the Chief Financial Officer, detailing his background at Sprout, Arthur Andersen, and Ernst & Young. The document also outlines the firm's strategy regarding Industry Advisors, specifically noting they use a broad network for Therapeutics rather than a formal board, while maintaining a specific advisory board for Information Convergence. The document bears a House Oversight stamp.
Events with shared participants
Acquisition of Interlace Medical by Hologix
Date unknown • N/A
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event